Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Affiliated Cancer Hospital of Shandong First Medical University, Jinan, Shandong